Rhenman & Partners Asset Management’s Ocular Therapeutix OCUL Stock Holding History

Rhenman & Partners Asset Management’s Portfolio OCUL Stock Details OCUL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$2.36M	Buy
2017 Q3	–	Sell
2017 Q2	$371K	Hold
2017 Q1	$371K	Hold
2016 Q4	$335K	Hold
2016 Q3	$275K	Hold
2016 Q2	$198K	Hold
2016 Q1	$386K	Buy